VR Logo

Unrated

Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan


Equity: Sectoral-Pharma

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 17.60 0.64 0.80 -0.87 6.17 16.84 -- -- -- -- --
S&P BSE Healthcare TRI 23.09 0.60 1.08 1.64 13.14 22.15 -- -- -- -- --
Equity: Sectoral-Pharma 24.45 0.45 0.98 0.43 10.03 23.28 -- -- -- -- --
Rank within category 9 3 6 7 8 9 -- -- -- -- --
Number of funds in category 9 9 9 9 9 9 8 4 3 3 3

As on 09-Jul-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-19 -- -- -- 2.72 247
Nippon India Pharma Fund
Unrated
Jun-04 35.56 13.44 6.96 2.24 2,992
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 38.49 -- -- 2.24 1,460
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 35.90 5.04 0.55 2.33 1,154
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 41.95 -- -- 2.51 581

Best & Worst Performance

Best (Period) Worst (Period)
Week 19.98 (01-Apr-2020 - 09-Apr-2020) -12.18 (11-Mar-2020 - 18-Mar-2020)
Month 29.68 (25-Mar-2020 - 24-Apr-2020) -20.14 (20-Feb-2020 - 23-Mar-2020)
Quarter 37.72 (23-Mar-2020 - 22-Jun-2020) -11.53 (23-Dec-2019 - 23-Mar-2020)
Year -- ( - ) -- ( - )

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 7.72 22.96 0.11 0.24 -- --
Equity: Sectoral-Pharma* 10.16 20.10 0.24 0.51 0.85 2.81
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 30-Jun-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 22
Top 10 Stocks (%) 63.81
Top 5 Stocks (%) 41.39
Top 3 Sectors (%) 96.65
Portfolio P/B Ratio 3.75
Portfolio P/E Ratio 33.80

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 29,010 29,284
Giant (%) 9.86 11.15
Large (%) 48.20 50.23
Mid (%) 30.00 23.97
Small (%) 11.93 14.65
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Cipla Healthcare 33.30 10.57 4.96 10.57
up Dr. Reddy's Lab Healthcare 31.97 9.64 4.40 9.64
up Sun Pharmaceutical Inds. Healthcare 30.72 12.47 8.29 9.20
up Divi's Laboratories Healthcare 41.96 7.86 5.41 6.91
down Lupin Healthcare -- 9.19 2.92 5.08
up Atul Chemicals 20.92 5.95 3.67 4.89
up Zydus Wellness FMCG 55.89 4.83 3.25 4.68
up Cadila Healthcare Healthcare 30.98 4.63 0.00 4.63
up Biocon Healthcare 65.13 4.40 2.71 4.35
down Apollo Hospitals Healthcare 42.92 6.13 3.88 3.88
equal Torrent Pharmaceuticals Healthcare 39.02 5.69 3.77 3.77
equal Avenue Therapeutics Inc Healthcare -- 3.42
equal Alembic Pharmaceuticals Healthcare 21.23 3.14 2.78 3.14
up Ipca Laboratories Healthcare 34.29 3.75 0.00 2.97
up Sanofi India Healthcare 43.00 4.02 2.61 2.96
equal Strides Pharma Science Healthcare 103.65 3.35 2.52 2.83
up Pfizer Healthcare 37.04 3.75 0.00 2.73
equal Alkem Laboratories Healthcare 25.70 5.95 2.73 2.73
equal Metropolis Healthcare Healthcare 58.09 4.05 2.34 2.41
equal Eris Lifesciences Healthcare 20.36 3.16 2.23 2.23
equal Narayana Hrudayalaya Healthcare 48.42 1.90 0.00 1.62
equal Aster DM Healthcare Healthcare 22.22 2.12 0.00 1.11
up Indoco Remedies Healthcare 79.08 1.14 0.00 0.93

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2020

Fund Manager

— Dhaval Shah since 20-Jun-2019

Education: Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.

Experience: Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.

Funds Managed:


0.64%

Change from previous, NAV as on 09-Jul-2020

Growth: ₹ 12.5600

Dividend: ₹ 12.5600


Investment Strategy

The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

Investment Details

Minimum Investment (₹) 1,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 6
Minimum Withdrawal (₹) --
Minimum Balance (₹) 500
Exit Load 0.5% for redemption within 90 days

Basic Details

Fund House: Aditya Birla Sun Life Mutual Fund
Launch Date: 10-Jul-2019
Return Since Launch: 25.60%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 247 Cr (As on 31-May-2020)
Expense: 2.72% (As on 31-May-2020)
Risk Grade: --
Return Grade: --
Turnover: 38.00%

Contact Information

AMC: Aditya Birla Sun Life AMC Ltd.

Address: One India Bulls Center - Tower 1, 17th Floor - Jupiter Mills Compound, 841 Senapati Bhawan, Elphinstone Road, Mumbai - 400013

Phone: 022-43568000 / 1800-270-7000 / 1800-22-7000

Fax: 022-43568110

Website: http://mutualfund.adityabirlacapital.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

VR Helpline

Investing rationally when markets are irrational.

dateSaturday, 11-Jul-2020
time04:00 PM - 04:30 PM